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Abstract
Background: Continuous monitoring of central venous oxygen saturation (ScvO2) has been proposed as a
prognostic indicator in several pathological conditions, including cardiac diseases, sepsis, trauma. To our
knowledge, no studies have evaluated ScvO2 in polytraumatized patients with brain injury so far. Thus, the aim of
the present study was to assess the prognostic role of ScvO2 monitoring during first 24 hours after trauma in this
patients' population.
Methods:  This prospective, non-controlled study, carried out between April 2006 and March 2008, was
performed in a higher level Trauma Center in Florence (Italy). In the study period, 121 patients affected by major
brain injury after major trauma were recruited. Inclusion criteria were: 1. Glasgow Coma Scale (GCS) score ≤
13; 2. an Injury Severity Score (ISS) ≥ 15. Exclusion criteria included: 1. pregnancy; 2. age < 14 years; 3. isolated
head trauma; 4. death within the first 24 hours from the event; 5. the lack of ScvO2 monitoring within 2 hours
from the trauma. Demographic and clinical data were collected, including Abbreviated Injury Scale (AIS), Injury
Severity Score (ISS), Simplified Acute Physiologic Score II (SAPS II), Marshall score. The worst values of lactate
and ScvO2 within the first 24 hours from trauma, ICU length of stay (LOS), and 28-day mortality were recorded.
Results: Patients who deceased within 28 days showed higher age (53 ± 16.6 vs 43.8 ± 19.6, P = 0.043), ISS core
(39.3 ± 14 vs 30.3 ± 10.1, P < 0.001), AIS score for head/neck (4.5 ± 0.7 vs 3.4 ± 1.2, P = 0.001), SAPS II score
(51.3 ± 14.1 vs 42.5 ± 15, P = 0.014), Marshall Score (3.5 ± 0.7 vs 2.3 ± 0.7, P < 0.001) and arterial lactate
concentration (3.3 ± 1.8 vs 6.7 ± 4.2, P < 0.001), than survived patients, whereas ScvO2 resulted significantly lower
(66.7% ± 11.9 vs 70.1% ± 8.9 vs, respectively; P = 0.046). Patients with ScvO2 values ≤ 65% also showed higher
28-days mortality rate (31.3% vs 13.5%, P = 0.034), ICU LOS (28.5 ± 15.2 vs 16.6 ± 13.8, P < 0.001), and total
hospital LOS (45.1 ± 20.8 vs 33.2 ± 24, P = 0.046) than patients with ScvO2 > 65%.
Conclusion: ScvO2 value less than 65%, measured in the first 24 hours after admission in patients with major
trauma and head injury, was associated with higher mortality and prolonged hospitalization.
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Background
Organ and tissue damages caused by a trauma impact lead
to the development of systemic inflammatory response
syndrome (SIRS) [1]. The local and systemic release of
inflammation mediators produces oxidative stress, capil-
lary leakage, microcirculatory disturbances, metabolic
alteration, imbalance of pro- and anti-inflammatory
mechanisms, ischaemia/reperfusion injury, coagulation
disturbances [1]. In major trauma, occult tissue hypoper-
fusion within the first 24 hours after event precedes mul-
tiple organ dysfunction syndrome (MODS) [2]. Despite
the unquestionable usefulness of routinely monitoring of
hemodynamic parameters, such as arterial lactate, central
venous pressure, blood pressure, heart rate, urinary vol-
ume, hypoxia may exist despite normal clinical values [3].
Continuous monitoring of central venous oxygen satura-
tion (ScvO2) has been proposed as an indicator of tissue
hypoperfusion. Although the reliability of ScvO2, com-
pared with mixed venous oxygen saturation (SvO2), is still
under discussion, particularly under shock conditions [3],
the prognostic importance of low level (≤ 65%) of ScvO2
has been highlighted in severe sepsis [4,5], myocardial
infarction [6], cardiac failure [7], and trauma [8]. Moreo-
ver, ScvO2 can be easily monitored with a central venous
line, whereas SvO2 requires a pulmonary artery catheteri-
zation.
In a recent investigation about the cause of death in
trauma Soreige K et al.[9] found a high percentage of head
trauma (67%) and concluded that focus on brain injuries
prevention is imperative.
To our knowledge, no studies have evaluated ScvO2 in
patients affected by brain injury after major trauma so far.
Thus, the aim of the present investigations was to assess
the useful of an early monitoring (first 24 hours) of ScvO2
in patients with major trauma and head injury.
Methods
Data collection
The study population was recruited from the Intensive
Care Unit (ICU) of Careggi Teaching Hospital (Florence,
Italy) from 1st April 2006 to 31st March 2008. The Car-
eggi Teaching Hospital is an a university-affiliated tertiary
care hospital of Tuscany (IT) and acts as the provincial
higher level trauma center for trauma. The ICU is a 10-sin-
gle bed multidisciplinary medical/surgical/trauma unit
that cares primarily patients of Emergency Department.
Patients were treated according to international standard
care [10] and to Advanced Trauma Life Support guide
lines (see Additional file 1), and were hemodynamically
stabilized according to vital signs such as heart rate, blood
pressure, and central venous pressure. Other parameters
considered in the evaluation of severity of hypovolemia
were the need for vasoactive drugs after hemodynamic
resuscitation and the number of blood units adminis-
tered. Inclusion criteria were: 1. admission diagnosis for
major trauma with head injury; 2. a Glasgow Coma Scale
(GCS) score ≤ 13, evaluated in the pre-hospital setting
before sedation; 3. an Injury Severity Score (ISS) ≥ 15; 4.
Exclusion criteria included: 1. pregnancy; 2. age < 14
years; 3. isolated head trauma; 4. death within the first 24
hours from the event; 5. the lack of ScvO2 monitoring
within 2 hours from the trauma. This prospective observa-
tional study, followed the principles of the Helsinki dec-
laration and national ethical guidelines. The study was
authorized by the Local Scientific committee and the
Local Ethic Committee, which waved the need of the
informed consent because it did not modify the therapeu-
tic approach provided by the current guide lines and inter-
nal protocols.
Patients' demographic and clinical characteristics were
extracted from institutional ICU-database (software: File-
Maker Pro 5.5v2, FileMaker, Inc, USA). All data have been
collected prospectively by two trained data collectors.
Patients has been anonymized, thus privacy was guaran-
tee. Severity of disease was estimated by the Simplified
Acute Physiology Score II (SAPS II) [11], a gravity score
validated in 1993, submitted to a recent revision [12]
(whose score is easily calculable on the site http://
www.sfar.org/scores2/saps2.html), GCS, ISS, and AIS. The
severity of the intracranial lesions was evaluated by the
Marshall radiological score [13] (table 1) from the first
CT-scan performed at hospital admission. Continuous
monitoring of ScvO2 was performed with Vigileo system
(Edwards Lifesciences, Irvine, California, USA). Central
catheter was placed within the first two hours after admis-
sion in all patients enrolled. During the first 24 hours after
trauma, both minimum value of ScvO2, measured for at
least 15 minutes during the first 24 hours after trauma,
and highest arterial lactate concentration were recorded.
The data collectors verified that these values were not
affected by episodic hypoxia during tracheal tube change,
fibrobronchoscopy, occasional hypotension.
Statistical Analysis
All analyses were performed using SPSS 10.0 statistical
software package (SPSS, Chicago, Illinois, USA). Student's
t-test was used for the numerical data, and two-tailed P
value was considered significant if less than 0.05. Categor-
ical data have been analysed with Fisher's exact test, with
two-sided P significant if < 0.05. The cut-off values have
been chosen based on statistically significant mean values
of subgroups analysis. Multiple logistic regression has
been performed on demographic and clinical parameters.
A value of < 0.05 was considered significant.Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:23 http://www.sjtrem.com/content/17/1/23
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Results
Overall population
In the study period, 121 patients met the inclusion crite-
ria. 255 patients were admitted to the Emergency Room
with ISS > 15 and GCS < 13; of these 21 died in the first
24 hours, 63 did not confirm a low GCS at the secondary
evaluation and, in 50 of these the insertion of venous cen-
tral catheter in the first 2 hours from trauma was not pos-
sible. Overall patients' demographic and clinical
characteristics and comparison between 28-days survived
and deceased patients are summarised in Table 2. Patients
enrolled had a prevalence of head/neck and chest injury,
as resulted from AIS score (Table 2). Male sex was pre-
dominant in both groups and represents 78% of overall
population. This gender prevalence is in accordance on
what usually observed in our clinical practice. On average,
deceased patients showed a significant higher age (53 ±
16.6 vs 43.8 ± 19.6, P = 0.043), ISS core (39.3 ± 14 vs 30.3
± 10.1, P < 0.001), AIS score for head/neck (4.5 ± 0.7 vs
3.4 ± 1.2, P = 0.001), SAPS II score (51.3 ± 14.1 vs 42.5 ±
15, P = 0.014), and Marshall Score (3.5 ± 0.7 vs 2.3 ± 0.7,
P < 0.001), if compared with survived patients. Consist-
ently with these observations, survived and deceased
patients resulted significantly different in arterial lactate
concentration (3.3 ± 1.8 vs 6.7 ± 4.2, respectively; P <
0.001) and ScvO2 (70.1% ± 8.9 vs 66.7% ± 11.9, respec-
tively; P = 0.046) (Table 2).
Mortality
The observed overall 28-days mortality rate was 18.2%.
According with the differences between survived and
deceased patients, contingency analysis showed that the
Table 1: Marshall Score [13].
MARSHALL SCORE
Diffuse injury I no visible pathology
Diffuse injury II cisterns present, midline shift 0–5 mm and/or lesion densities present or no mass lesion > 25 ml
Diffuse injury III (swelling) cisterns compressed or absent with midline shift 0–5 mm or no mass lesion > 25 ml
Diffuse injury IV (shift) midline shift > 5 mm, no mass lesion > 25 ml; neurosurgery; high or mixed-density lesion > 25 ml, not surgically 
evacuated
The score is based on the severity of intracranial lesions identified at head CT scan
Table 2: Demographic and clinical characteristics of overall population and comparison between survived and deceased patients at 28 
days.
Overall Deceased Survived P
Number 121 22 99
Age (years) 45.5 ± 19.3 53 ± 16.6 43.8 ± 19.6* 0.043
Male sex, % (N) 77.7% (94) 77.3% (17) 77.8% (77) 0.813
ISS score 32 ± 11.4 39.3 ± 14 30.3 ± 10.1* < 0.001
AIS score 11.7 ± 3.3 12.6 ± 14.1 11.5 ± 3.1 0.117
Head/Neck 3.6 ± 1.2 4.5 ± 0.7 3.4 ± 1.2* 0.001
Face 1.8 ± 1.3 1.5 ± 1.2 1.8 ± 1.3 0.313
Chest 2.5 ± 1.1 2.8 ± 0.7 2.4 ± 1.2 0.495
Abdominal 1.0 ± 1.4 0.7 ± 1.1 1.1 ± 1.4 0.174
Extremity 1.5 ± 1.4 1.2 ± 1.6 1.6 ± 1.3 0.064
External 1.3 ± 0.8 1.3 ± 0.7 1.3 ± 0.8 0.886
SAPS II score 44.1 ± 15.2 51.3 ± 14.1 42.5 ± 15* 0.014
GCS score 7.2 ± 3.1 6.5 ± 3.2 7.4 ± 3 0.096
Marshall Score 2.6 ± 0.8 3.5 ± 0.7 2.3 ± 0.7* < 0.001
ScvO2, % 70.9% ± 8 66.7% ± 11.9 70.1% ± 8.9* 0.046
HR (beats/min) 108 ± 23 110 ± 30 107 ± 28 0.744
MAP (mmHg) 79 ± 11 78 ± 16 80 ± 14 0.575
CVP (mmHg) 13 ± 2 12 ± 4 14 ± 6 0.861
Lactate (mmol/l) 4 ± 2.8 6.7 ± 4.2 3.3 ± 1.8* < 0.001
ScvO2 level was the worst value measured for at least 15 minutes during the first 24 hours after trauma. Lactate concentration was the worst value 
measured during the first 24 hours after trauma.
Data are expressed as mean ± standard deviation (SD). Percent data are referred to the total population of each group.
Statistical analysis: two-tail Student's t-test. P-values were considered significant if less than 0.05 (*).
ISS: Injury Severity Score; AIS: Abbreviate Injury Scale; SAPS: Simplified Acute Physiology Score; GCS: Glasgow Coma Scale; ScvO2: central venous 
oxygen saturation; HR: heart rate; MAP: mean arterial pressure; CVP: central venous pressure.Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:23 http://www.sjtrem.com/content/17/1/23
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significant relative risks for death were identified in age >
40 yrs, AIS (head/neck) ≥ 4, ISS score above 30, SAPS II
score above 45, Marshall score > 2, lactate concentration
> 3, and ScvO2 ≤ 65% (Table 3). A multiple regression
analysis performed on parameters with a higher correla-
tion with 28-days mortality showed that variables which
mostly contributed to the prediction of mortality were
Marshall score (P = 0.001) and lactate concentration (P =
0.002). The calculation of concordance rate between two
multiple regression analysis showed that adding ScvO2 to
the other variables considered (age, AIS for head/neck,
ISS, SAPS II, Marshall score and lactate concentration),
raised the rate of correct predictions of 1% (from 86.6%
to 87.6%).
Subgroup analysis
Subgroup analysis of overall population, based on an
ScvO2 value of ≤ 65%, showed that patients with worst
ScvO2 had a significantly higher 28-days mortality rate
(31.3% vs 13.5%, P = 0.034) respect to the comparison
group (Table 4). Also total intra-ICU mortality (34.4% vs
13.5%, P = 0.017) and total intra-hospital mortality
(37.5% vs 14.6%, P = 0.010) resulted significantly higher
in ScvO2 ≤ 65% group respect to the ScvO2 > 65% group
(Table 4). Moreover, the ScvO2 ≤ 65% group significantly
differed in age (54.5 ± 18.3 vs 42.2 ± 18.8, P = 0.002), ISS
score (36.1 ± 10.3 vs 30.5 ± 11.5, P = 0.018), total AIS
score (12.94 ± 2.9 vs 11.3 ± 3.3, P = 0.016), AIS score for
extremity (2.2 ± 1.7 vs 1.3 ± 1.2, P = 0.001), SAPS II score
(51.1 ± 15.0 vs 41.6 ± 14.5, P = 0.002), and GCS score (5.7
± 2.7 vs 7.8 ± 3.0, P = 0.001) from patients with ScvO2 >
65% (Table 4). Conversely, Marshall score and lactate val-
ues did not differ significantly between the two groups
(Table 4).
Discussion
The aim of the present investigation was to assess the role
of early ScvO2 monitoring in trauma patients with associ-
ated head injury. We assumed that a persistent low ScvO2
could be the expression of the dangerous effects of gener-
alized and, concomitant, brain hypoperfusion in patients
with brain injury and major trauma and, therefore, that it
could predict a worst evolution.
The prognostic importance of low level (≤ 65%) of ScvO2
has been emphasized in severe sepsis [4,5], myocardial
Table 3: Results of the relative risk analysis (95% confidence interval) related to 28-day mortality.
RR 95% CI P Sens Spec PPV NPV
Age ≥ 40 * 2.7 1.1–7 0.032 0.77 0.46 0.25 0.91
Age ≥ 45 - - 0.198 - - - -
Age ≥ 50 - - 0.113 - - - -
AIS (Head/Neck) ≥ 3- - 0 . 2 7 2 - - - -
AIS (Head/Neck) ≥ 4 * 4.1 1.3–13.1 0.007 0.86 0.46 0.26 0.94
ISS ≥ 30 * 3 1.2–7.7 0.017 0.77 0.53 0.27 0.91
ISS ≥ 35 * 3.8 1.7–8.7 0.001 0.68 0.71 0.35 0.91
ISS ≥ 40 * 2.4 1.149–5 0.03 0.46 0.79 0.32 0.87
SAPS II ≥ 40 - - 0.188 - - - -
SAPS II ≥ 45 * 2.9 1.2–6.9 0.017 0.73 0.58 0.28 0.91
SAPS II ≥ 50 * 2.3 1.1–4.8 0.046 0.55 0.7 0.29 0.87
Marshall score ≥ 2 * 14.7 3.6–60.1 < 0.001 0.91 0.71 0.41 0.97
Marshall score ≥ 3 * 5.8 2.8–12 < 0.001 0.59 0.89 0.54 0.91
Lactate ≥ 3 mmol/l * 6.8 1.7–27.8 < 0.001 0.90 0.51 0.30 0.96
Lactate ≥ 4 mmol/l * 4.8 1.9–12.3 < 0.001 0.75 0.70 0.37 0.92
Lactate ≥ 5 mmol/l * 4.2 2–9 < 0.001 0.55 0.85 0.46 0.89
ScvO2 ≤ 65% * 2.3 1.1–4.8 0.034 0.46 0.78 0.31 0.87
ScvO2 ≤ 70% - - 0.186 - - - -
The cut-off values have been chosen based on statistically significant mean values of subgroups analysis (survived vs deceased patients, see Table 2).
Statistical analyses were performed using the two-tails Fisher's exact test (95% confidence interval). P-values were considered significant if less than 
0.05 (*).
RR: Relative Risk; CI: Confidence Interval; Sens: Sensitivity; Spec: Specificity; PPV = Positive Predictive Value; NPV = Negative Predictive Value; 
SAPS: Simplified Acute Physiology Score; GCS: Glasgow Coma Scale; ISS: Injury Severity Score; AIS: Abbreviate Injury Scale; ScvO2: central venous 
oxygen saturation.Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:23 http://www.sjtrem.com/content/17/1/23
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infarction [6], and cardiac failure [7]. The significance of
ScvO2 in patients with major trauma has been previously
reported in 26 injured patients [8]. In their investigation,
Scalea and co-workers found that ScvO2 measurement was
a trustworthy parameter to estimate blood loss, especially
in patients who showed an ScvO2 below 65% despite sta-
ble clinical signs [8]. In opposition with this observation,
a subsequent study did not confirm the reliability of
ScvO2 as indicator of blood loss in 40 trauma patients
[14]. According with Scalea et al., the lack of linear corre-
lation between low ScvO2 and stable clinical signs has
been also corroborated by Rady and colleagues in a non-
randomized study on sixteen patients presenting to the
emergency department in shock conditions, who pre-
sented ScvO2 below 65% in almost 50% of cases, despite
the hemodynamic stabilization [5].
The ScvO2 cut-off value of ≤ 65% has been chosen in the
present investigation based on existing literature [5,8,14]
and on the average we found in our patients deceased at
28 days (66.7%, Table 2). The main finding of this study
was the relationship between an ScvO2 values ≤ 65%, for
at least 15 minutes during the first 24 hours from trauma,
and mortality rates (Table 4). It must be noted that in the
group with lower ScvO2 also injury scores and lactate lev-
els were worst. In regard, the absolute significance of
ScvO2 in predicting mortality in the multivariate analysis
was lower than Marshall score and lactate levels in our
investigation. However, the inclusion of ScvO2 in a multi-
ple regression model showed that mortality prediction
can be improved from 86.6% to 87.6%: this improve-
ment, whereas not ample, could be relevant in the day to
day clinical practice. In consideration of our results,
ScvO2should be never considered as a substitute of lactate
monitoring or injury scores in predicting outcome. In
addition to these observations, patients with ScvO2 values
> 65% discharged alive from ICU, showed significantly
reduction in both ICU and total hospital LOS (Table 4).
Table 4: Comparison of demographic and clinical characteristics of overall patients.
Overall patients
ScvO2 ≤ 65% ScvO2 > 65% P
Number 32 89 0.002
Age (years) 54.5 ± 18.3 42.2 ± 18.8* 0.491
Male sex, % (N) 71.9% (23) 79.8% (71) 0.018
ISS score 36.1 ± 10.3 30.5 ± 11.5* 0.016
AIS score§ 13 ± 11,5 10 ± 9* 0.324
Head/Neck 3 ± 1 3 ± 1 0.674
Face 2 ± 1 2 ± 1 0.625
Chest 3 ± 1 2.5 ± 1 0.38
Abdominal 1 ± 1 1 ± 1 < 0.001
Extremity 2 ± 1 1 ± 1* 0.362
External 1 ± 1 1 ± 1 0.002
SAPS II score 51.1 ± 15.0 41.6 ± 14.5* 0.001
GCS score 5.7 ± 2.7 7.8 ± 3.0* 0.109
Marshall Score§ 2.5 ± 2 2 ± 2 < 0.001
ScvO2. % 59% ± 5 74% ± 6* 0.078
Lactate (mmol/l) 4.5 ± 2.4 3.7 ± 2.9 0.127
HR (beats/min) 113 ± 21 109 ± 27 0.211
MAP (mmHg) 78 ± 14 82 ± 13 0.344
CVP (mmHg) 11 ± 3 11 ± 2 < 0.001
ICU LOS (days) 28.5 ± 15.2 16.6 ± 13.8* 0.046
Hospital LOS (days) 45.1 ± 20.8 33.2 ± 24* 0.034
28-days mortality, % (N) 31.3% (10) 13.5% (12)* 0.017
Total intra-ICU mortality, % (N) 34.4% (11) 13.5% (12)* 0.010
Total intra-hospital mortality, % (N) 37.5% (12) 14.6% (13)* 0.002
Subgroups analysis was based on the ScvO2 values (≤ 65% vs > 65%) measured during the first 24 hours from trauma event. ScvO2 level was the 
worst value measured for at least 15 minutes during the first 24 hours after trauma. Lactate concentration was the worst value measured during the 
first 24 hours after trauma. ICU LOS and hospital LOS have been calculated on patients discharged alive from ICU and from hospital, respectively. 
Total intra-ICU mortality included one patient died in ICU after readmission.
Data are expressed as mean ± standard deviation (SD). Percent data are referred to the total population of each group.
Statistical analysis: two-tails Student's t-test, two-sides Fisher's exact test. P-values were considered significant if less than 0.05 (*).
ISS: Injury Severity Score; AIS: Abbreviate Injury Scale; SAPS: Simplified Acute Physiology Score; GCS: Glasgow Coma Scale; ScvO2: central venous 
oxygen saturation; HR: heart rate; MAP: mean arterial pressure; CVP: central venous pressure.
§ Median ± interquartile rangeScandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:23 http://www.sjtrem.com/content/17/1/23
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Our findings are partially in accordance with a recent
study performed on 96 critically ill patients admitted in a
multidisciplinary ICU, in which an ScvO2 value below
60% at admission was related with high mortality rate but
not with a prolonged ICU LOS [15]. On regard, it must be
considered that the study of Bracht and co-workers was
performed on unselected critically ill patients, with a not
specified number of central nervous system injured
patients (less than 30% of total patients enrolled),
whereas our population included polytraumatized
patients with head injury. In our study, the association
between low level of ScvO2  and ICU/hospital LOS
appeared strong; however, this finding could be also
related with the differences in age and injuries observed in
the two subgroups (Table 4).
The most numerous and extensive studies on ScvO2 opti-
mization have been performed on septic patients. To our
knowledge, no study has investigated the usefulness of
ScvO2 monitoring to guide hemodynamic stabilization
and to improve outcome in patients with major trauma
[3]. The pathogenic changes following major trauma
include SIRS, oxidative stress, capillary leakage, metabolic
alterations, and diffuse tissue hypoxia as a result of circu-
latory abnormalities [1]. This pathophysiological process
is somehow very similar with what observed in septic
patients, although sepsis presents a different aetiology,
evolution and possibility to be treated with antibiosis. In
our investigation, ScvO2  was not included as a target
parameter for hemodynamic optimization, so none can
be gathered from our data on application of early-goal
directed therapy protocol in major trauma. Nevertheless,
considering the good evidence in patients with severe sep-
sis/septic shock, the use of ScvO2 to guide hemodynamic
optimization in polytraumatized patients would merit to
be adequately investigated.
Limits of present findings merit considerations. 1) We did
not included data on fluids administration in the first 24
hours, brain damages evolutions, intracranial pressure,
and their relationship with ScvO2  levels. Second, the
exclusion of patients who died in the first 24 hours from
the study protocol might be a potential bias. The reason of
this choice depended from our goal to investigate the role
of ScvO2 in the first 24 hours, which are considered critical
in the evolution of MODS in polytrauma [2]. Third, we
were not blinded for the primary end points (but in an
emergency setting is not so easy), but the collection of
data was made by an external investigator that was blind
for the end points. Finally, the lack of a control group with
a pulmonary artery catheter with SvO2 monitoring did not
allow a comparison between ScvO2 and SvO2, although
previous studies showed that changes of both values pro-
ceed in a parallel manner, even under shock conditions
[3,16].
Conclusion
In conclusion, an early monitoring of ScvO2 could aid to
predict the outcome in patients with major trauma and
head injury. In particular, we found that a value less than
65%, measured during the first 24 hours after admission,
was associated with higher mortality rate and prolonged
ICU and hospital LOS. So, our results seem to suggest the
use of ScvO2 as a target of resuscitation in patients with
brain injury after major trauma. The validation of ScvO2
in monitoring of cerebral metabolism and as a target for
hemodynamic resuscitation in polytraumatized patients
remains to be investigated.
Key messages
• ScvO2 should be monitored in patients with major
trauma, especially if head injury coexists.
￿ ScvO2 value less than 65%, measured in the first 24
hours after admission, is associated with higher mortality
and prolonged ICU/hospital LOS.
￿ ScvO2 as a prognostic indicator should be considered in
its relationship with typology of injuries and the other ill-
ness scores.
Abbreviations
AIS: abbreviated injury scale; GCS: Glasgow coma scale;
ICU: intensive care unit; ISS: injuryseverity score; LOS:
length of stay, MODS: multiple organ dysfunction syn-
drome; SAPS II: simplified acute physiology score II; SIRS:
systemic inflammatory response syndrome; ScvO2: central
venous oxygen saturation; SvO2: mixed venous oxygen
saturation.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
ADF and AP planned the study and reviewed the litera-
ture. ADF, CG and AP wrote the manuscript. MC and GZ
performed the statistical analyses. GFG, RS, LP and CG
participated in the design ofthe study. LP and CG col-
lected data and helped draft the manuscript. GZ revised
the manuscript. All authors have seen and approved the
final revised version.
Additional material
Additional file 1
Appendix on trauma. Major diagnostic and therapeutic procedures in the 
treatment of trauma in the Tuscany Region, Italy.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1757-
7241-17-23-S1.doc]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:23 http://www.sjtrem.com/content/17/1/23
Page 7 of 7
(page number not for citation purposes)
Acknowledgements
The authors acknowledge Dr. Paola Nicoletti for her contributions to the 
revising and editing of the manuscript. The study was supported by institu-
tional funds.
References
1. Keel M, Trentz O: Pathophysiology of polytrauma.  Injury 2005,
36:691-709.
2. Blow O, Magliore L, Claridge JA, Butler K, Young JS: The golden
hour and the silver day: detection and correction of occult
hypoperfusion within 24 hours improves outcome from
major trauma.  J Trauma 1999, 47:964-969.
3. Reinhart K, Bloos F: The value of venous oximetry.  Curr Opin Crit
Care 2005, 11:259-263.
4. Krafft P, Steltzer H, Hiesmayr M, Klimscha W, Hammerle AF: Mixed
venous oxygen saturation in critically ill septic shock
patients. The role of defined events.  Chest 1993, 103:900-906.
5. Rady MY, Rivers EP, Martin GB, Smithline H, Appelton T, Nowak RM:
Continuous central venous oximetry and shock index in the
emergency department: use in the evaluation of clinical
shock.  Am J Emerg Med 1992, 10:538-541.
6. Astiz ME, Rackow EC, Kaufman B, Falk JL, Weil MH: Relationship of
oxygen delivery and mixed venous oxygenation to lactic aci-
dosis in patients with sepsis and acute myocardial infarction.
Crit Care Med 1988, 16:655-658.
7. Ander DS, Jaggi M, Rivers E, Rady MY, Levine TB, Levine AB, Masura
J, Gryzbowski M: Undetected cardiogenic shock in patients
with congestive heart failure presenting to the emergency
department.  Am J Cardiol 1998, 82:888-891.
8. Scalea TM, Hartnett RW, Duncan AO, Atweh NA, Phillips TF, Sclafani
SJ, Fuortes M, Shaftan GW: Central venous oxygen saturation: a
useful clinical tool in trauma patients.  J Trauma 1990,
30:1539-1543.
9. Søreide K, Krüger AJ, Vårdal AL, Ellingsen CL, Søreide E, Lossius HM:
Epidemiology and contemporary patterns of trauma deaths:
changing place, similar pace, older face.  World J Surg 2007,
31:2092-103.
10. Fowler RA, Adhikari NK, Scales DC, Lee WL, Rubenfeld GD:
Update in critical care 2007.  Am J Respir Crit Care Med 2008,
177:808-819.
11. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Phys-
iology Score (SAPS II) based on a European/North Ameri-
can multicenter study.  JAMA 1993, 270:2957-63.
12. Le Gall JR, Neumann A, Hemery F, Bleriot JP, Fulgencio JP, Garrigues
B, Gouzes C, Lepage E, Moine P, Villers D: Mortality prediction
using SAPS II: an update for French intensive care units.  Crit
Care 2005, 9:636-7.
13. Marshall LF, Marshall SB, Klauber MR, Van Berkum Clark M, Eisenberg
H, Jane JA, Luerssen TG, Marmarou A, Foulkes MA: The diagnosis
of head injury requires a classification based on computed
axial tomography.  J Neurotrauma.  1992, 9(Suppl 1):S287-S292.
14. Bannon MP, O'Neill CM, Martin M, Ilstrup DM, Fish NM, Barrett J:
Central venous oxygen saturation, arterial base deficit, and
lactate concentration in trauma patients.  Am Surg 1995,
61:738-745.
15. Bracht H, Hanggi M, Jeker B, Wegmuller N, Porta F, Tuller D, Takala
J, Jakob SM: Incidence of low central venous oxygen saturation
during unplanned admissions in a multidisciplinary intensive
care unit: an observational study.  Crit Care 2007, 11:R2.
16. Reinhart K, Kuhn HJ, Hartog C, Bredle DL: Continuous central
venous and pulmonary artery oxygen saturation monitoring
in the critically ill.  Intensive Care Med 2004, 30:1572-1578.